PHILADELPHIA, (November 20, 2015) - The two newest residents of the University City Science Center’s Port business incubator are taking on oral pain management and developing next-generation oncology therapeutics.
FyMed is a pharmaceutical company focused on drug development through sophisticated biomarker discovery methodologies in precision medicine. Starting with products for oral pain management, FyMed is utilizing novel markers based on immunomodulation therapy using NSAIDs. FyMed’s lab is located at 3624 Market Street.
Viventia Bio has established its U.S. headquarters at the Science Center’s Port facility at 3711 Market Street as part of the Global Soft Landing program. Based in Winnipeg, Canada, Viventia Bio is developing next-generation oncology therapeutics utilizing a proprietary Targeted Protein Therapeutic technology (TPT). The company’s novel TPTs have been designed to overcome the efficacy and safety challenges of existing antibody-drug conjugates.
The Science Center’s Port business incubator helps emerging life sciences, physical sciences, and digital technology companies operate and grow through a suite of related programs and facilities. The Port provides co‐working spaces, cubicles, fully furnished offices, and/or wet and dry labs directly in the heart of the Science Center’s original campus at uCity Square. Beyond the physical infrastructure, Port residents are immediately plugged in to a rich network of resources where they can access the programs, the people and the support that can help grow their businesses. Port resident companies raised more than $150 million in private capital from 2009-2014.
About the Science Center
The University City Science Center is a dynamic hub for innovation, and entrepreneurship and technology development in the Greater Philadelphia region. It provides business incubation, programming, lab and office facilities, and support services for entrepreneurs, start-ups, and growing and established companies. Since it was founded in 1963, graduate organizations and current residents of the University City Science Center’s Port business incubators have created more than 15,000 jobs that remain in the Greater Philadelphia region today and contribute more than $9 billion to the regional economy annually. The Science Center is leveraging its history as the nation’s oldest and largest urban research park as it joins forces with Wexford Science + Technology, a BioMed Realty company, to expand its footprint and rebrand its physical campus as uCity Square, a mixed-use community of ingenuity where bright minds will flourish and thrive. For more information about the Science Center, go to http://ucscreview.org/.
